Evaluation of selected antiprotozoal drugs in the Babesia microti- hamster model

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 91-94

  Marley, Sara E ^a,b   Eberhard, Mark L ^a,d   Steurer, Frank J ^a   Ellis, William L ^c   McGreevy, Patrick B ^c   Ruebush II, Trenton K ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; ARTESUNATE; HALOFANTRINE; MEFLOQUINE; TAFENOQUINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIOSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG ELIMINATION; HAMSTER; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIASIS; MALARIA; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL;

EID: 0031027258     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.91     Document Type: Article

References (22)

1. Anderson, J. F., E. D. Mintz, J. J. Gadbaw, and L. A. Magnarelli. 1991. Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut. J. Clin. Microbiol. 29:277-2783.
2. Anderson, S. L., A. L. Ager, P. McGreevy, B. G. Schuster, W. Ellis, and J. Berman. 1994. Efficacy of azithromycin as a causal prophylactic agent against murine malaria. Antimicrob. Agents Chemother. 38:1862-1863.
3. Benezra, D., A. E. Brown, B. Polsky, J. W. M. Gold, and D. Armstrong. 1987. Babesiosis and infection with human immunodeficiency virus. Ann. Intern. Med. 107:944. (Letter.)
4. Etkind, P., J. Piesman, T. K. Ruebush, A. Spielman, and D. D. Juranek. 1980. Methods for detecting Babesia microti infection in wild rodents. J. Prasitol. 66:107-110.
5. Gleason, N. N., G. R. Healy, K. A. Western, G. D. Benson, and M. G. Shultz. 1970. The "Gray" strain of Babesia microti from a human case established in laboratory animals. J. Parasitol. 56: 1256-1257.
6. Gombert, M. E., E. J. C. Goldstein, J. L. Benach, M. J. Tenenbaum, E. Grunwaldt, M. H. Kaplan, and L. K. Eveland. 1982. Human babesiosis: clinical and therapetic considerations. JAMA 248:3005-3007.
7. Herwaldt, B. L., F. E. Springs, P. P. Roberts, M. L. Eberhard, K. Case, D. H. Persing, and W. A. Agar. 1995. Babesiosis in Wisconsin: a potentially fatal disease. Am. J. Trop. Med. Hyg. 53:146-151.
8. Hughes, W. T., and H. S. Oz. 1995. Successful prevention and treatment of babesiosis with atovaquone. J. Infect. Dis. 172:1042-1046.
9. Krause, P. J., S. R. Telford, Jr., R. J. Pollack, R. Ryan, P. Brassard, L. Zemel, and A. Spielman. 1992. Babesiosis: an underdiagnosed disease of children. Pediatrics 89:1045-1048.
10. Krause, P. J., and H. M. Feder, Jr. 1994. Lyme disease and babesiosis. Adv. Pediatr. Infect. Dis. 9:183-209.
11. Marcus, L. C., C. J. Mabray, and G. H. Sturgis. 1984. Babesia microti infection in the hamster: failure of quinine and pyrimethamine in chemotherapeutic trials. Am. J. Trop. Med. Hyg. 33:21-23.
12. Quick, R. E., B. L. Herwaldt, J. W. Thomford, M. E. Garnett, M. L. Eberhard, M. Wilson, D. H. Spach, J. W. Dickerson, S. R. Telford, K. R. Steingart, R. Pollock, D. H. Persing, J. M. Kobayashi, D. D. Juranek, and P. A. Conrad. 1993. Babesiosis in Washington State: a new species of Babesia? Ann. Intern. Med. 119:284-290.
13. Persing, D. H., B. L. Herwaldt, C. Glaser, R. S. Lane, J. W. Thomford, D. Mathiesen, P. J. Krause, D. F. Phillip, and P. A. Conrad. 1995. Infection with a Babesia-like organism in northern California. N. Engl. J. Med. 332:298-303.
14. Rosner, F., M. H. Zarrabi, J. L. Benach, and G. S. Habicht. 1984. Babesiosis in splenectomized adults: review of 22 reported cases. Am. J. Med. 78:696-701.
15. Rowin, K. S., H. B. Tanowitz, and M. Wittner. 1982. Therapy of experimental babesiosis. Ann. Intern. Med. 97:556-558.
16. Ruebush, T. K., II. 1980. Human babesiosis in North America. Trans. R. Soc. Trop. Med. Hyg. 74:149-152.
17. Ruebush, T. K., II. P. G Contacos, and E. A. Steck. 1980. Chemotherapy of Babesia microti infections in Mongolia jirds. Antimicrob. Agents Chemother. 18:289-291.
18. Ruebush, T. K., II. 1994. Babesiosis, p. 1345-1347. In P. D. Hoeprich, M. C. Jordan, and A. R. Ronald (ed.), Infectious diseases, 5th ed. J. B. Lippincott, Philadelphia, Pa.
19. Smith, R. P., A. T. Evans, M. Papovsky, L. Mills, and A. Spielman. 1986. Transfusion-acquired babesiosis and failure of antibiotic treatment. JAMA 256:2726-2727.
20. Villar, B. F., D. J. White, and J. L. Benach. 1991. Human babesiosis, p. 129-143. In T. Sun (ed.), Progress in clinical parasitology, vol. 2. Field and Wood Medical Publishers, Inc., New York, N.Y.
21. Weiss, L. M., M. Wittner, S. Wasserman, H. S. Oz, J. Retsema, and H. B. Tanowitz. 1993. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J. Infect. Dis. 168:1289-1292.
22. Wittner, M., K. S. Rowin, H. B. Tanowitz, J. F. Hobbs, S. Saltman, B. Wenz, R. Hirsch, E. Chisholm, and G. R. Healy. 1982. Successful chemotherapy of transfusion babesiosis. Ann. Intern. Med. 96:601-604.